regulatory efficiency and the 2020 strategy of the generic and biosimilar medicines
Published 7 years ago • 125 plays • Length 3:11Download video MP4
Download video MP3
Similar videos
-
14:19
regulatory pathway for biosimilars
-
59:48
generic drugs and biosimilars 101
-
5:14
effectiveness of generic and biosimilar medications
-
1:36
interchangeable biosimilars
-
0:37
the generic and biosimilar industry has a plan to secure our medicines -- #secureourmeds
-
1:44
fast facts about the regulatory approval pathway for biosimilars – amgen science
-
1:32
the regulation of biosimilars
-
4:05
the biosimilar regulatory pathway
-
1:26:16
15 years of biosimilars - online webinar
-
14:31
biosimilars and interchangeables - regulatory highlights (27of33) quality – oct. 16-17, 2019
-
2:25
what are generic & biosimilar medicine manufacturers doing to expand access to their products?
-
2:39
regulatory principles for biosimilar medicines
-
49:37
busting the myths on affordable medicine: how generics and biosimilars drive savings, not costs
-
7:30
generics and biosimilars
-
47:38
winship grand rounds september 13, 2017: r. donald harvey, pharmd
-
0:48
exploring the future of generics and biosimilars at grx biosims 2024
-
56:23
"biosimilars" by prateek mendiratta, md & indrani kar, pharmd
-
3:57
challenges in biosimilar acceptance
-
0:22
key contributions of the generics and biosimilars medicines industry